Cambridge Isotope, Chemtatva Chiral Solutions Announce ₹300 Crore Investment in Telangana.

Cambridge Isotope Laboratories, Inc. (CIL), a US-based producer of stable isotope-labelled compounds, has partnered with Chemtatva Chiral Solutions Pvt Ltd, a Hyderabad-based speciality chemicals manufacturer, to establish a strategic joint venture aimed at building advanced manufacturing capabilities in Telangana.

The joint venture plans to invest around ₹300 crore over the next three years in Genome Valley Phase 4, a major life sciences cluster near Hyderabad. The project is expected to generate more than 250 jobs and strengthen India’s capabilities in manufacturing isotopically labelled molecules used in pharmaceutical research, diagnostics, advanced electronics and semiconductor applications.

“Stable isotopes and labelled molecules are essential tools for modern pharmaceutical research, diagnostics and emerging electronics applications. The proposed facility will manufacture a wide range of stable isotope-labelled compounds that are critical for drug discovery, metabolic studies, diagnostics and advanced materials research,” said Shakthi M. Nagappan, CEO of Telangana Life Sciences, in a statement on Saturday.